Try our Advanced Search for more refined results
Gedeon Richter PLC
-
Utility | Filed: June 03, 2022 | Entered: June 03, 2022 Allergan USA, Inc. et al v. Aurobindo Pharma Limited et al
Patent - Abbreviated New Drug Application(ANDA) | Delaware
- CORRECTING ENTRY
CORRECTING ENTRY: The pdf for the Order at D.I. 266 has been replaced with a corrected version. The date on the Order has been corrected to reflect it was signed on June 1, 2022. The Order at D.I. 267 has also been replaced with this corrected version. The NEFs for each filing has been regenerated. (nms)
-
Misc | Filed: June 02, 2022 | Entered: June 02, 2022 Allergan USA, Inc. et al v. Aurobindo Pharma Limited et al
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Patent/Trademark Report to Commissioner of Patents
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,737,142 B2; 7,943,621 B2; 8,569,497 B2; 8,765,765 B2; 8,569,496 B2; RE 47,350 E. (Attachments: # 1 Order)(nms)
-
Order | Filed: June 01, 2022 | Entered: June 01, 2022 Allergan USA, Inc. et al v. Aurobindo Pharma Limited et al
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Order ~Util - Add and Terminate Parties ~Util - Terminate Civil Case
SO ORDERED Granting 265 Stipulation and Order of Dismissal between Plaintiffs and Aurobindo Defendants (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 6/1/2022. (nms)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login